Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
2,233 total articles
Halozyme is trading near $76 after raising 2026 guidance, securing Surf Bio and projecting royalty revenue north of $1 billion. The setup supports a long trade toward $95 over the next 180 trading days, while acknowledging execution and clinical risks. Entry $76.21, stop $64.00, target $95.00.
Deckers reported a blowout 3Q and raised fiscal 2026 guidance, driven by HOKA strength and resilient UGG demand. Fundamentals and cash flow back a buy here; technicals show momentum and short-interest is modest. Trade plan: enter $118.00, stop $108.00, target $150.00 over a long-term (180 trading days) horizon.
Hitachi is a diversified industrial with a growing Digital Systems & Services segment that looks increasingly SaaS-like. With a $162.2B market cap, improving technicals and supportive macro drivers for Japanese equities, we reiterate a buy and propose a position trade sized to risk a 2.4% stop under today's level. The thesis is tactical: own exposu…
Oshkosh (OSK) appears undervalued relative to its cash generation and defense exposure. With an enterprise value near $10.1B, free cash flow of $754.8M and a P/E in the mid-teens, the risk/reward favors a long position. We outline an actionable trade with entry, stop and target while flagging the operational and macro risks that could derail the se…
JBS N.V. offers an attractive risk-reward into 2026: cash-flowing protein assets, recent liability rationalization and consistent global demand point to upside from $15.72, but commodity cycles, FX and event risk argue for a disciplined entry and tight stop. This trade idea lays out an actionable long with entry, stop and target and explains the fu…
AppLovin's AI-inflected growth story still looks impressive on top-line metrics, but steep multiples, bearish technical momentum, and crowded positioning set up a mid-term short. We lay out an entry at $484.10, a stop at $525.00, and a target of $350.00 over ~45 trading days, with clear catalysts and risk management.
Eastman (EMN) looks set to have bottomed operationally. Stabilizing volumes, improving technical momentum, and a 4.8% yield make a constructive swing trade. Entry at $72.00, stop at $65.00, target $86.00 over a mid-term (45 trading days) horizon. Risk/reward and balance sheet metrics support a medium-risk long with clearly defined failure condition…
Atlas Copco (ATLKY) looks set to benefit from improving industrial demand and structural growth in compressors, vacuum solutions, and power tools. The shares are close to their 52-week high and trade at a premium multiple, so this is a measured, mid-term trade that balances upside from cyclical recovery with limited margin for error. Entry $20.96, …
LifeMD (LFMD) is a pure telehealth play with an integrated pharmacy strategy and a recently refreshed GLP-1 pricing partnership that improves patient access. The company trades at a modest EV/Sales and is free-cash-flow positive despite negative GAAP earnings. This trade idea targets a measured long entry at $3.28 with a $5.00 primary target over a…
Paul Mueller Company (MUEL) is an overlooked industrial equipment business with recent organic growth, strong Q2 margins, a low float, and corporate actions that should support a rerating. This trade idea lays out an actionable long with entry at $450.00, a stop at $410.00 and a $575.00 target over the next 45 trading days.
Cadence (CDNS) is a key software platform for semiconductor design and verification. Recent weakness has pulled the stock near $289, giving a measured long opportunity for traders who believe AI-driven ASIC design, strong free cash flow, and a rebound in China will re-accelerate growth. This trade idea lays out entry, stop, target, catalysts, and t…
U-Haul (UHAL) trades at roughly $57 with an enterprise value of about $17.4B and a P/E north of 50, yet it produced negative free cash flow last year and posts sub-3% ROE. Operational opacity across moving & storage, insurance, and life insurance has compressed margins and left the stock vulnerable. This trade idea puts a mid-term (45 trading days)…
SoFi's shares have been pummeled despite continued operational progress: EPS prints, member growth and new product partnerships (including a Bitcoin Lightning remittance rollout) point to accelerating revenue diversification. Technicals show oversold momentum and a compressed risk/reward. This is a tactical, mid-term long with a clear entry, stop a…
Fractyl Health's share price has been crushed to penny-stock territory despite multiple positive clinical updates and tangible near-term clinical-program optionality. The company trades at a market cap of roughly $63M with enterprise value under $24M, negative free cash flow but identifiable upcoming program milestones. This trade idea takes a prag…
Meta's latest quarter surprised on both revenue and profit and, crucially, left investors encouraged by 2026 capital spending that looks targeted at AI and ad-product improvements. With $46.1B in free cash flow, a $1.79T enterprise value around current prices, and bullish technicals, this is a trade to open on strength with defined risk. I outline …
Fidelity National Financial (FNF) is trading near $55 with a mid-teens P/E discount to peers in insurance and an attractive free cash flow profile. Recent corporate actions and a reliable $0.50 quarterly dividend argue for a re-rate. This trade idea outlines a clear entry, stop and target with a mid-term horizon and balanced risk framing.
<p>Apple reported another blowout quarter and the market shrugged off skeptics — the stock is my top trade idea on the long side. Strong iPhone demand in Asia and India, disciplined AI-related capital allocation, and $123B of free cash flow create a resilient earnings engine that supports valuation and potential upside.</p>
Alaska Air Group (ALK) has spent the past year reshaping its fleet and narrative. The company's landmark Boeing order and improving momentum give a reasonable setup for a swing trade: enter on a pullback, target a re-rating toward peers as capacity and efficiency improvements are priced in, and defend with a tight stop under recent technical suppor…
Uber is generating real free cash flow and earnings while trading at a single-digit-ish P/E for a tech-enabled platform. That disconnect creates a tradeable mid-term opportunity into Q4 results: buy a measured position on weakness, protect with a clear stop, and target a re-rating if margins or guidance stabilize.
Texas Instruments is breaking out of a multi-year range after Q4 2025 strength and bullish 2026 guidance. With Data Center end-market growth, steady Industrial demand, a sizeable dividend, and a disciplined capital return program, TXN looks positioned for a multi-month gain. The trade below balances momentum and valuation risk with a clear stop and…
Baidu sits at the intersection of steady ad cash flow, fast-growing AI/cloud revenue and a plausible corporate-finance pivot toward dividends or buybacks. At a $54.3B market cap and a PE near 49, the stock is priced for continued growth but also offers an asymmetric setup if management signals a shareholder-return program. This trade idea targets a…
Charter (CHTR) trades around 6x reported earnings with roughly $4.4B in annual free cash flow and an enterprise value of ~$122B. Leverage is high, but the business generates consistent broadband cash flow, trades well below historical multiples, and has clear catalysts (broadband market tailwinds, potential legal clarity, and cost discipline). We u…
Oracle announced a $45-50 billion funding plan to bulk up Oracle Cloud Infrastructure. That plan flips a typical cloud-growth story into an execution-and-financing event. Given high leverage, negative free cash flow, and a stretched valuation, this is a pragmatic mid-term short (45 trading days) to capture further normalization as investors digest …
B2Gold's Goose Mine has moved from commissioning to commercial production and is slated to contribute roughly 300,000 ounces per year from 2026-2031. That ramp creates a clear path to a step-change in free cash flow relative to the company's current market capitalization. This trade idea outlines a long-biased position to capture the re-rating as o…
ASML's monopoly on EUV lithography is powering another leg of compounding: record Q4 orders (€13.2bn), 2026 guidance raised to €34-39bn and a €12bn buyback underpin growth and capital returns. Technicals show bullish momentum, but a steep valuation (PE ~51, PB ~24.7) and China exposure create near-term jolt risk. Trade plan: go long at $1426.74, ta…
